Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in systemic sclerosis
NCT00555581Phase 2Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Aug 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of imatinib in systemic sclerosis (SSc), sponsored by Hospital for Special Surgery. Primary endpoint: Modified Rodnan Skin Score at 12 months. Started Aug 2007; status: completed.
02
Drugs
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00555581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555581.